Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gábor Barna

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Pathology Oncology Research : POR|February 16, 2026
Editorial: Cytometry in oncologyGábor Barna, József Dudás
Hematological Oncology|April 3, 2008
The cut-off levels of CD23 expression in the differential diagnosis of MCL and CLLGábor Barna, Lilla Reiniger, Péter Tátrai, et al.
International Journal of Cancer|July 10, 2025
CD86, the double agent: Significance of CD86 expression in B-cell malignanciesGábor Barna, Gábor Szalóki, Ágnes Márk, et al.
Experimental Cell Research|July 24, 2007
Smad4-independent, PP2A-dependent apoptotic effect of exogenous transforming growth factor beta 1 in lymphoma cellsAnna Sebestyén, Melinda Hajdu, Lilla Kis, et al.
Cell Biology International|September 8, 2012
Heparin can liberate high molecular weight DNA from secondary necrotic cellsGábor Barna, Anna Sebestyén, Zsuzsanna A Dunai, et al.
Magyar Onkologia|December 10, 2024
[The clinical potential of measurable residual disease in hematological malignancies]Tamás László, Anna Lili Kenéz, Gabriella Szepesi, et al.
Anticancer Research|November 29, 2005
Different ways to induce apoptosis by fenretinide and all-trans-retinoic acid in human B lymphoma cellsGábor Barna, Anna Sebestyén, Silke Weischede, et al.
Acta Oncologica (Stockholm, Sweden)|January 25, 2021
Identification of a novel resistance mechanism in venetoclax treatment and its prediction in chronic lymphocytic leukemiaFerenc Takács, Gábor Mikala, Noémi Nagy, et al.
Experimental Dermatology|February 8, 2013
Cutaneous lymphocyte-associated antigen as a novel predictive marker of TNF-alpha inhibitor biological therapy in psoriasisHajnalka Jókai, József Szakonyi, Orsolya Kontár, et al.
Annals of Hematology|June 30, 2018
In contrast to high CD49d, low CXCR4 expression indicates the dependency of chronic lymphocytic leukemia (CLL) cells on the microenvironmentCsilla Kriston, Márk Plander, Ágnes Márk, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Pathology Oncology Research : POR|February 16, 2026
Editorial: Cytometry in oncologyGábor Barna, József Dudás
Hematological Oncology|April 3, 2008
The cut-off levels of CD23 expression in the differential diagnosis of MCL and CLLGábor Barna, Lilla Reiniger, Péter Tátrai, et al.
International Journal of Cancer|July 10, 2025
CD86, the double agent: Significance of CD86 expression in B-cell malignanciesGábor Barna, Gábor Szalóki, Ágnes Márk, et al.
Experimental Cell Research|July 24, 2007
Smad4-independent, PP2A-dependent apoptotic effect of exogenous transforming growth factor beta 1 in lymphoma cellsAnna Sebestyén, Melinda Hajdu, Lilla Kis, et al.
Cell Biology International|September 8, 2012
Heparin can liberate high molecular weight DNA from secondary necrotic cellsGábor Barna, Anna Sebestyén, Zsuzsanna A Dunai, et al.
Magyar Onkologia|December 10, 2024
[The clinical potential of measurable residual disease in hematological malignancies]Tamás László, Anna Lili Kenéz, Gabriella Szepesi, et al.
Anticancer Research|November 29, 2005
Different ways to induce apoptosis by fenretinide and all-trans-retinoic acid in human B lymphoma cellsGábor Barna, Anna Sebestyén, Silke Weischede, et al.
Acta Oncologica (Stockholm, Sweden)|January 25, 2021
Identification of a novel resistance mechanism in venetoclax treatment and its prediction in chronic lymphocytic leukemiaFerenc Takács, Gábor Mikala, Noémi Nagy, et al.
Experimental Dermatology|February 8, 2013
Cutaneous lymphocyte-associated antigen as a novel predictive marker of TNF-alpha inhibitor biological therapy in psoriasisHajnalka Jókai, József Szakonyi, Orsolya Kontár, et al.
Annals of Hematology|June 30, 2018
In contrast to high CD49d, low CXCR4 expression indicates the dependency of chronic lymphocytic leukemia (CLL) cells on the microenvironmentCsilla Kriston, Márk Plander, Ágnes Márk, et al.
Pageof 6